Stock HRTX HERON THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Heron Therapeutics, Inc.

Equities

HRTX

US4277461020

Real-time Estimate Cboe BZX
Other stock markets
 03:15:53 2024-05-15 pm EDT 		5-day change 1st Jan Change
2.985 USD +6.23% Intraday chart for Heron Therapeutics, Inc. -0.83% +75.59%
May. 07 Transcript : Heron Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024
May. 07 Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Heron Therapeutics : Investor Day Presentation
PU
Transcript : Heron Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024
Heron Therapeutics: Q1 Earnings Snapshot
AQ
Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
PR
Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
PR
Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target
MT
Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
PR
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
PR
Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024
CI
Heron Therapeutics : Q4 2023 Earnings Call Presentation
PU
Health Care Down on Rotation to Rate-Sensitive Sectors -- Health Care Roundup
DJ
Sector Update: Health Care Stocks Slipping Late Afternoon
MT
Heron Therapeutics Shares Soar After Q4 Results Beat
MT
Needham Adjusts Price Target on Heron Therapeutics to $5 From $4, Keeps Buy Rating
MT
Heron Therapeutics : Q4 2023 Earnings Call Presentation
PU
Heron Therapeutics: Q4 Earnings Snapshot
AQ
Transcript : Heron Therapeutics, Inc., Q4 2023 Earnings Call, Mar 12, 2024
Heron Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Earnings Flash (HRTX) HERON THERAPEUTICS Posts Q4 Revenue $34.2M, vs. Street Est of $31.2M
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HRTX Stock
  4. News Heron Therapeutics, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW